Clinical Trials

What Is A Trial?

A clinical trial tests new treatments before they are available to patients through the mainstream market.  These new treatments are tested extensively, first in the laboratory and then in a series of studies called phase I, II and III clinical trials. These studies are done under very controlled conditions in order to determine if promising approaches to disease prevention, diagnosis, and treatment are safe and effective.

Types Of Clinical Trials

  • Treatment trials test new treatments (like a new drug, new approaches to surgery or radiation therapy, new combinations of treatments, or new methods such as gene therapy).
  • Prevention trials test new approaches, such as medicines, vitamins, minerals, or other supplements that doctors believe may lower the risk of disease.
  • Screening trials test the best way to find a disease such as cancer, especially in its early stages.

How Can I Be Referred?

By combining the genitourinary research programs at the Vancouver Prostate Centre and the BC Cancer Agency, clinical trial patients can participate in a full range of investigational studies. Patients interested in participating should contact their doctor for referral.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Fathers Day Walk Run 2019

Raymond James Father's Day Walk Run Fundraiser, June 16, 2019

The 21st Annual Raymond James Walk Run fundraiser for Prostate Cancer Foundation BC took place on Sunday June 16, 2019 in various locations across BC. The sponsorship page is still accepting donations;  click here to sponsor our Centre's team (opens in new window).

 

Employment

Work at the Vancouver Prostate Centre

Monday, July 8, 2019

Dr. Flannigan to lead clinical trial for scrotal pain treatment

Dr. Flannigan
Monday, June 3, 2019

Benefits Seen With Apalutamide Plus ADT in Metastatic Castration-Sensitive Prostate Cancer

Dr. Chi